DSIP Nasal Spray: Intranasal Research Format

DSIP nasal spray research centers on a single question: can delta sleep-inducing peptide (DSIP), a small nine-amino-acid neuropeptide implicated in sleep-regulating pathways, be delivered across the nasal mucosa in a form suitable for controlled laboratory study? This product guide examines the intranasal DSIP research format from a mechanistic standpoint — why investigators pair a sleep-pathway neuropeptide with a nasal route, what physicochemical properties matter for a research preparation, and how the format compares with reconstituted alternatives in preclinical and in-vitro work.

Research Use Only (RUO). All products and information referenced here are for laboratory research use only. They are not for human or veterinary use, are not intended to diagnose, treat, cure, or prevent any disease, and have not been evaluated by the FDA. Nothing below is dosing guidance, medical advice, or a health claim. Handling instructions describe laboratory preparation of a research material only.

What DSIP is at the molecular level

Delta sleep-inducing peptide is a linear nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) and a molecular weight near 848 Da. It was first isolated from cerebral venous blood in early sleep-physiology experiments and named for its association with delta-wave (slow-wave) EEG activity in animal models. As a research analyte, DSIP is notable for its small size, hydrophilic character, and rapid distribution — properties that make delivery route a genuinely interesting variable rather than an afterthought. For a fuller treatment of the molecule and its history, see our DSIP Research Guide: Delta Sleep Peptide.

Why the sleep pathway is the mechanistic anchor

DSIP does not act on a single cleanly characterized receptor the way many peptides do; instead, research has examined its interactions with several sleep- and stress-related systems. Studies have investigated modulation of the hypothalamic-pituitary-adrenal (HPA) axis, interactions with GABAergic and glutamatergic tone, and effects on corticotropin and somatostatin release in animal models. Because these targets sit within or upstream of central sleep-regulating circuitry, the delivery route that shortens or alters the path to the central nervous system becomes mechanistically relevant. That is the premise a nasal research format is built to probe. Our DSIP & Sleep Architecture: Mechanism Explainer unpacks the slow-wave and neuroendocrine pathways in detail.

Why an intranasal format for DSIP research

The nasal cavity presents a large, thin, highly vascularized mucosal surface. For research purposes, two features draw investigators to it. First, the respiratory epithelium offers a transmucosal absorption surface that bypasses first-pass hepatic metabolism — a meaningful consideration for a small peptide that is otherwise degraded quickly. Second, the olfactory and trigeminal regions provide anatomically direct interfaces with the central nervous system, and the nose-to-brain hypothesis — that some fraction of an intranasally applied molecule reaches CNS compartments along perineural and perivascular routes — is an active area of preclinical study. For a sleep-pathway neuropeptide whose targets are central, that hypothesis is the entire reason the format is interesting. The mechanism is covered generally in our Intranasal Peptide Delivery: Mechanism Guide.

Physicochemical factors studied for nasal DSIP preparations

• Molecular weight: at ~848 Da, DSIP sits below the informal ~1 kDa threshold above which passive paracellular nasal transport drops sharply — a favorable starting point for transmucosal research.
• Solubility: DSIP's hydrophilic residues support aqueous formulation, relevant to preparing a stable research spray solution.
• Enzymatic stability: nasal aminopeptidases can degrade peptides; research models examine formulation strategies and residence time as variables.
• Mucociliary clearance: the nasal cavity clears material on a roughly 15–20 minute timescale, which constrains the contact window and is a standard experimental parameter.

The intranasal DSIP research format in practice

A nasal-spray research format supplies DSIP as (or reconstituted into) an aqueous solution delivered by a metered actuator that produces a droplet plume rather than a stream. In a laboratory setting this format is studied because it standardizes the applied volume per actuation and the deposition pattern across the nasal mucosa — both important when the experimental question concerns route and mucosal contact rather than peptide identity alone.

Laboratory handling of a DSIP research preparation

These points describe handling of the material as a research reagent, not any use in a subject:

• Reconstitution: where supplied as lyophilized powder, bacteriostatic or sterile water is typically used to prepare the stock solution; the peptide is added gently down the vial wall to avoid shear.
• Concentration control: because a metered spray fixes volume per actuation, the concentration of the prepared solution defines the mass delivered per actuation in the experimental design.
• Storage: reconstituted DSIP solutions are generally stored refrigerated (2–8 °C) for short-term work and frozen (−20 °C or colder) for longer-term storage; lyophilized material is kept desiccated and cold. Repeated freeze-thaw cycles are minimized to preserve integrity.
• Documentation: lot-specific purity and identity should be confirmed against the third-party certificate of analysis (COA) before any assay.

Nasal format vs reconstituted vial: what the comparison studies

Both formats begin from the same molecule, so the research distinction is about route and delivery geometry, not chemistry. A reconstituted vial supports flexible volume and precise mass handling for in-vitro assays; a nasal-spray format standardizes mucosal deposition for route-of-administration research models.

Our Nasal Spray vs Reconstituted Peptide Formats comparison expands this framework, and researchers examining related nasal neuropeptides may find the parallel Selank Nasal Spray: Intranasal Research Format guide useful for cross-format context.

Positioning within nasal-format research

DSIP is one of several neuropeptides investigated in intranasal form; what distinguishes it is the direct alignment between a central sleep-pathway target and a route hypothesized to favor central exposure. That alignment is why the intranasal DSIP format recurs in sleep-neuroendocrine research design. For the broader category framework, return to our pillar overview, Peptide Nasal Spray Research Formats.

Researchers sourcing material for these studies can review specifications and the third-party COA for our DSIP 5mg research peptide, supplied at ≥99% purity with same-day USA shipping. For lot documentation or ordering questions, contact neurolabsresearch3@gmail.com.